日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers

一种首创的Wiskott-Aldrich综合征蛋白激活剂,对血液肿瘤具有抗肿瘤活性

Spriano, Filippo; Sartori, Giulio; Sgrignani, Jacopo; Barnabei, Laura; Arribas, Alberto J; Guala, Matilde; Del Amor, Ana Maria Carrasco; Tomasso, Meagan R; Tarantelli, Chiara; Cascione, Luciano; Golino, Gaetanina; Riveiro, Maria E; Bortolozzi, Roberta; Lupia, Antonio; Paduano, Francesco; Huguet, Samuel; Rezai, Keyvan; Rinaldi, Andrea; Margheriti, Francesco; Ventura, Pedro; Guarda, Greta; Costa, Giosuè; Rocca, Roberta; Furlan, Alberto; Verdonk, Luuk M; Innocenti, Paolo; Martin, Nathaniel I; Viola, Giampietro; Driessen, Christoph; Zucca, Emanuele; Stathis, Anastasios; Gahtory, Digvijay; Van den Nieuwboer, Maurits; Bornhauser, Beat; Alcaro, Stefano; Trapasso, Francesco; Cristobal, Susana; Padrick, Shae B; Pazzi, Natalina; Cavalli, Franco; Cavalli, Andrea; Gaudio, Eugenio; Bertoni, Francesco

Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy

靶向肾上腺髓质素治疗肿瘤:一种可行的策略,其潜力远超一种替代性的抗血管生成疗法

Vázquez, Ramiro; Riveiro, Maria E; Berenguer-Daizé, Caroline; O'Kane, Anthony; Gormley, Julie; Touzelet, Olivier; Rezai, Keyvan; Bekradda, Mohamed; Ouafik, L'Houcine

BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance.

BET溴结构域抑制剂birabresib在套细胞淋巴瘤中的体内活性及克服适应性耐药性的新组合的鉴定

Tarantelli Chiara, Bernasconi Elena, Gaudio Eugenio, Cascione Luciano, Restelli Valentina, Arribas Alberto Jesus, Spriano Filippo, Rinaldi Andrea, Mensah Afua Adjeiwaa, Kwee Ivo, Ponzoni Maurilio MD, Zucca Emanuele, Carrassa Laura, Riveiro Maria E, Rezai Keyvan, Stathis Anastasios, Cvitkovic Esteban, Bertoni Francesco

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers

一项针对既往接受过治疗的复发性或转移性孕激素受体表达癌症女性患者的 I 期研究,评估了 I 型抗孕激素奥那普酮的疗效。

Cottu, Paul H; Bonneterre, Jacques; Varga, Andrea; Campone, Mario; Leary, Alexandra; Floquet, Anne; Berton-Rigaud, Dominique; Sablin, Marie-Paule; Lesoin, Anne; Rezai, Keyvan; Lokiec, François M; Lhomme, Catherine; Bosq, Jacques; Bexon, Alice S; Gilles, Erard M; Proniuk, Stefan; Dieras, Veronique; Jackson, David M; Zukiwski, Alexander; Italiano, Antoine

Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma

溴结构域抑制剂OTX015(MK-8628)与靶向药物联合使用,在淋巴瘤中显示出强大的体内抗肿瘤活性。

Gaudio, Eugenio; Tarantelli, Chiara; Ponzoni, Maurilio; Odore, Elodie; Rezai, Keyvan; Bernasconi, Elena; Cascione, Luciano; Rinaldi, Andrea; Stathis, Anastasios; Riveiro, Eugenia; Cvitkovic, Esteban; Zucca, Emanuele; Bertoni, Francesco